D-0171-2025 Class II Ongoing
FDA drug recall D-0171-2025 was initiated by VIONA PHARMACEUTICALS INC on Dec 10, 2024 and is designated Class II. Reason for recall: Crystallization The recall status is ongoing. Affected quantity: 23304 packs.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 8, 2025
- Initiation Date
- Dec 10, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23304 packs
Product description
Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02. packaged in an Airless pump pack
Reason for recall
Crystallization
Distribution pattern
US Nationwide
Code information
Lots T400513, Exp Date 02/2026; T400807, Exp Date 03/2026; T401152, Exp Date 06/2026; T401303, Exp Date 07/2026; T401304, Exp Date 07/2026; T401399, Exp Date 07/2026 & T401696 Exp Date 08/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0171-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026